IBDEI2E4 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40557,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,40557,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,40558,0)
 ;;=D69.0^^159^1993^32
 ;;^UTILITY(U,$J,358.3,40558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40558,1,3,0)
 ;;=3^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,40558,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,40558,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,40559,0)
 ;;=B00.9^^159^1993^158
 ;;^UTILITY(U,$J,358.3,40559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40559,1,3,0)
 ;;=3^Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,40559,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,40559,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,40560,0)
 ;;=B02.9^^159^1993^291
 ;;^UTILITY(U,$J,358.3,40560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40560,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,40560,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,40560,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,40561,0)
 ;;=D17.9^^159^1993^89
 ;;^UTILITY(U,$J,358.3,40561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40561,1,3,0)
 ;;=3^Benign Lipomatous Neop,Unspec
 ;;^UTILITY(U,$J,358.3,40561,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,40561,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,40562,0)
 ;;=E08.621^^159^1993^134
 ;;^UTILITY(U,$J,358.3,40562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40562,1,3,0)
 ;;=3^DM d/t Underlying Condition w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,40562,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,40562,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,40563,0)
 ;;=E09.621^^159^1993^133
 ;;^UTILITY(U,$J,358.3,40563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40563,1,3,0)
 ;;=3^DM d/t Drug/Chemical w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,40563,1,4,0)
 ;;=4^E09.621
 ;;^UTILITY(U,$J,358.3,40563,2)
 ;;=^5002576
 ;;^UTILITY(U,$J,358.3,40564,0)
 ;;=H05.011^^159^1993^110
 ;;^UTILITY(U,$J,358.3,40564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40564,1,3,0)
 ;;=3^Cellulitis of Right Orbit
 ;;^UTILITY(U,$J,358.3,40564,1,4,0)
 ;;=4^H05.011
 ;;^UTILITY(U,$J,358.3,40564,2)
 ;;=^5004560
 ;;^UTILITY(U,$J,358.3,40565,0)
 ;;=H05.012^^159^1993^103
 ;;^UTILITY(U,$J,358.3,40565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40565,1,3,0)
 ;;=3^Cellulitis of Left Orbit
 ;;^UTILITY(U,$J,358.3,40565,1,4,0)
 ;;=4^H05.012
 ;;^UTILITY(U,$J,358.3,40565,2)
 ;;=^5004561
 ;;^UTILITY(U,$J,358.3,40566,0)
 ;;=H05.013^^159^1993^97
 ;;^UTILITY(U,$J,358.3,40566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40566,1,3,0)
 ;;=3^Cellulitis of Bilateral Orbits
 ;;^UTILITY(U,$J,358.3,40566,1,4,0)
 ;;=4^H05.013
 ;;^UTILITY(U,$J,358.3,40566,2)
 ;;=^5004562
 ;;^UTILITY(U,$J,358.3,40567,0)
 ;;=I70.331^^159^1993^50
 ;;^UTILITY(U,$J,358.3,40567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40567,1,3,0)
 ;;=3^Athscl Bypass of Right Leg w/ Ulcer of Thigh
 ;;^UTILITY(U,$J,358.3,40567,1,4,0)
 ;;=4^I70.331
 ;;^UTILITY(U,$J,358.3,40567,2)
 ;;=^5007626
 ;;^UTILITY(U,$J,358.3,40568,0)
 ;;=I70.332^^159^1993^51
 ;;^UTILITY(U,$J,358.3,40568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40568,1,3,0)
 ;;=3^Athscl Bypass of Right Leg w/ Ulcer of Calf
 ;;^UTILITY(U,$J,358.3,40568,1,4,0)
 ;;=4^I70.332
 ;;^UTILITY(U,$J,358.3,40568,2)
 ;;=^5007627
 ;;^UTILITY(U,$J,358.3,40569,0)
 ;;=I70.333^^159^1993^52
 ;;^UTILITY(U,$J,358.3,40569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40569,1,3,0)
 ;;=3^Athscl Bypass of Right Leg w/ Ulcer of Ankle
 ;;^UTILITY(U,$J,358.3,40569,1,4,0)
 ;;=4^I70.333
 ;;^UTILITY(U,$J,358.3,40569,2)
 ;;=^5007628
 ;;^UTILITY(U,$J,358.3,40570,0)
 ;;=I70.334^^159^1993^53
 ;;^UTILITY(U,$J,358.3,40570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40570,1,3,0)
 ;;=3^Athscl Bypass of Right Leg w/ Ulcer of Heel/Midfoot
